CYDNEY WIENS: Open Payments
NPI 1558893867 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 20 payments from 13 companies in 2025. Trend: 2023 $496 · 2024 $699 · 2025 $451
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 3 | $79 |
| Novo Nordisk Inc | 3 | $68 |
| ABIOMED | 3 | $65 |
| AtriCure, Inc. | 1 | $33 |
| Solventum Corporation | 2 | $32 |
| Endologix LLC | 1 | $31 |
| PolyNovo North America LLC | 1 | $28 |
| Bolton Medical Inc | 1 | $27 |
| Boston Scientific Corporation | 1 | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $20 |
Products named: ENDURANT IIS, Wegovy, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, Torus Stent Graft System, NOVOSORB BTM, RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM, ENROUTE Transcarotid Stent, LifeVest.
Industry payments across OK — which companies pay providers there.
